TiGenix amends follow-on

TiGenix N.V. (Euronext:TIG), Leuven, Belgium Business: Musculoskeletal, Gene/Cell therapy Date announced: 2016-02-03 Type: Follow-on To be raised: TBD Shares: TBD Price prior: EUR0.99 Underwriters: Ca...